[Confidence Level: High] NXI Therapeutics is a Basel-based biotechnology organization developing selective immunosuppressants that target the Coronin 1 signaling pathway to treat autoimmune diseases and organ transplant rejection.16
[Confidence Level: High] NXI Therapeutics is a Basel-based biotechnology organization developing selective immunosuppressants that target the Coronin 1 signaling pathway to treat autoimmune diseases and organ transplant rejection.16
This is an extract of the full organization profile. To access the full company profile, .
Desktop only
The Research module is designed for larger screens. Please reopen it on a desktop or laptop to use the screener, filters, detail pages, and admin tools.